Disease/Disorder | Type of genomic change | Brief description | Chromosome | Locus | Gene | Refs |
---|---|---|---|---|---|---|
Alzheimer’s disease | Single nucleotide variants | Low-level mosaic single nucleotide variants | 1 | 1q42.13 | PS2 | [53] |
14 | 14q24.2 | PS1 | ||||
17 | 17q21.31 | MAPT | ||||
21 | 21q21.3 | APP | ||||
Single nucleotide variants | Brain-specific single nucleotide variants | 2 | 2q32.2 | COL3A1 | [61] | |
4 | 4q31.3 | LRBA | ||||
Single gene mutations | Single gene autosomal dominant variants | 11 | 11q24.1 | SORL1 | [53] | |
Single nucleotide variants | Single nucleotide variants in the temporal cortex | 1 | 1q32.2 | CD55 | [62] | |
Single nucleotide variants | Pathogenic somatic mutation leading to a loss-of-function mutation | 19 | 19p13.2 | PIN1 | [63] | |
Single gene mutations | Accumulating of mosaic somatic mutations in autism/intellectual disability genes | 20 | 20q13.13 | ADNP | [64] | |
Nucleotide repeat expansion | Hexanucleotide repeat expansions | 9 | 9p21.2 | C9orf72 | [65] | |
CNVs | CNVs affecting ~ 10% of cells | NS* | NS | NS | [52] | |
CNV (gain) | Single gene amplification | 21 | 21q21.3 | APP | [66] | |
CNV (gain) | Single gene gain | 12 | 12q13.12 | PRPH | [65] | |
DNA content variation | Increased rates of DNA content variation (variations of DNA content in a cell suggested to hallmark aneuploidy/polyploidy) | — | — | — | ||
Aneuploidy | Increased rates of aneuploidy | 17 | — | — | ||
Aneuploidy (trisomy/monosomy) | Chromosome-specific (numerical) instability | 21 | Whole chromosome | — | [15] | |
Aneuploidy (monosomy) | X chromosome loss (an aging marker) | X | Whole chromosome | — | [46] | |
Aneuploidy (chromosome instability) | Chromosome missegregation and aneuploidy probably resulted from mutations in the APP, presenelin 1 and, probably, NPC1 | 21 | — | — | reviewed by [26] | |
Amyotrophic lateral sclerosis (sporadic) | CNVs | Brain-specific CNVs | 3 | 3p26.3p26.2 | CNTN4 | [68] |
8 | 8p23.2 | CSMD1 | ||||
22 | 22q11.22 | GGTLC2 | ||||
Ataxia telangiectasia (ATM mutations) | LINE-1 retrotransposition | Specific LINE-1 retrotransposition | — | — | — | [69] |
Aneuploidy (chromosome instability) and chromosome 14-specific instability (affecting exclusively this chromosome) | High rates of chromosome instability in degenerating areas of the brain suggested to have ATM mutations (aneuploidy, non-random chromosomal breaks, rearranged chromosomes) | 1, 7, 11, 13, 14, 17, 18, 21, X, Y | Whole chromosomes | — | ||
14 | 14q12 | NOVA1, FOXG1B | ||||
Autism spectrum disorder | Single gene mutations | Recurrent deleterious mutations | 2 | 2q24.3 | SCN1A | [35] |
2 | 2q24.3 | SCN2A | ||||
3 | 3p21.31 | SETD2 | ||||
6 | 6q25.3 | ARID1B | ||||
LINE-1 retrotransposition | LINE-1 overexpression in the cerebellum | — | — | — | [70] | |
Focal Cortical Dysplasia | Single nucleotide variants | Missense mutations | 9 | 9q34.13 | TSC1 | |
16 | 16p13.3 | TSC2 | ||||
1 | 1p36.22 | MTOR | [73] | |||
22 | 22q12.2q12.3 | DEPDC5 | [74] | |||
Focal cortical dysplasia, type II | Single nucleotide variants | Somatic doublet mutation | 7 | 7q36.1 | RHEB | [75] |
Hemimegalen-cephaly | Single nucleotide variants | Missense mutations | 1 | 1q43q44 | AKT3 | |
3 | 3q26.32 | PIK3CA | ||||
14 | 14q32.33 | AKT1 | ||||
Single nucleotide variants | Missense mutations | 1 | 1p36.22 | MTOR | [73] | |
Single nucleotide variants | “Double-hit” single nucleotide variants of two genes | 1 | 1p36.22 | MTOR | [77] | |
9 | 9p22.1 | RPS6 | ||||
Hypothalamic Hamartoma | Single nucleotide variants | Missense mutations | 7 | 7p14.1 | GLI3 | |
X | Xp22.2 | OFD1 | ||||
Frontotemporal lobar degeneration | Aneuploidy (trisomy) | Neuronal aneuploidy + apoptosis due to mitotic defects caused by MAPT mutations | 12, 21 | — | — | [80] |
Huntington’s disease | Nucleotide repeat expansion | Expansion of an unstable trinucleotide repeat (CAG) | 4 | 4p16.3 | HTT | [81] |
Lewy body diseases | Aneuploidy (NS) | Increase in neuronal DNA content (probably aneuploidy) | — | — | — | [82] |
Niemann-Pick disease, type C1 (NPC1 mutations) | Aneuploidy (trisomy) | Accumulation of (trisomic) cells with additional chromosome 21 in Niemann-Pick disease, type C1 | 21 | — | — | [83] |
Nonlesional focal epilepsy | Single gene mutations | Missense mutations, deletions (frameshift), insertions | X | Xp11.23 | SLC35A2 | [84] |
Parkinson’s disease | Single nucleotide variants | Questionable SNCA variants | 4 | 4q22.1 | SNCA | [85] |
CNV (gains) | Somatic SNCA gains in nigral dopaminergic neurons | 4 | 4q22.1 | SNCA | [86] | |
Rett syndrome (MECP2 mutations) | LINE-1 retrotransposition | Specific LINE-1 retrotransposition | — | — | — | [87] |
Schizophrenia | Single nucleotide variants | NS | NS | NS | NS | [88] |
CNV (loss) | Somatic deletions | 2 | 2q31.2 | PRKRA | [42] | |
5 | 5q35.2 | BOD1 | ||||
7 | 7p15.2 | CBX3 | ||||
CNVs (gains/losses) | Diseases-specific CNVs | 4 | 4q35.2 | NS | [43] | |
6 | 6p11.2 | |||||
7 | 7q11q12 | |||||
11 | 11p15.4p15.5 | |||||
15 | 15q11.2 | |||||
LINE-1 retrotransposition | Increased LINE-1 “burden” and LINE-1 insertions in synapse or schizophrenia-related genes | — | — | — | ||
Aneuploidy (trisomy) | Low-level mosaic trisomy | 18, X | — | — | [3] | |
Aneuploidy (trisomy/monosomy) | Low-level mosaic trisomy and monosomy | 1 | Whole chromosome | — | [40] | |
Aneuploidy (trisomy/monosomy) | Increased rates of gonosomal aneuploidy | X, Y | — | — | [41] | |
Sturge-Weber syndrome (leptomeningeal angiomatosis) | Single nucleotide variants | Missense mutation (R183Q) | 9 | 9q21.2 | GNAQ | [91] |
Subcortical band heterotopia (“double cortex” syndrome) | Single gene mutations | Mosaic gene mutations associated with the syndrome | 17 | 17p13.3 | PAFAH1B1 (LIS1) | |
X | Xq23 | DCX | ||||
Tuberous Sclerosis | Single nucleotide variants | Missense mutations | 16 | 16p13.3 | TSC2 | [94] |